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Monday, February 22, 2010 353aphosphorylation. Molecular modeling of cTnT-DK210 structure reveals
changes in the electrostatic environment of cTnT helix (residues 203-224)
that lead to a more basic environment around Thr203, which enhances PKC-de-
pendent phosphorylation. In addition, yeast two-hybrid assays indicate that
cTnT-DK210 has enhanced binding to cTnI compared with cTnT-wt, and
may impair Ca2þ sensing/transmission leading to myofilament desensitization.
Collectively, our observations suggest that cardiomyopathy-causing DK210
has far-reaching effects influencing posttranslational modifications of key sar-
comeric proteins, and potentially cTnI-cTnT interaction.
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Crystal structures of the troponin ‘‘core-domain’’ formed in the presence and
absence of Ca2þ display a bilobed TnC subunit mounted on a semi-rigid scaf-
fold formed from major stretches of TnI and TnT. A central coiled-coil of TnI
and TnT is flanked by single TnI and TnT helices to form the W-shaped sup-
porting structure, which appears to be little changed by the binding of Ca2þ
(Takeda et al., 2003; Vinogradova et al., 2005). In contrast, at low Ca2þ, the
central helix joining C- and N-lobes of TnC melts, and the ‘‘regulatory’’ C-ter-
minal domain of TnI dissociates from the N-lobe of TnC (Vinogradova et al.,
2005). Consistent with biochemical studies, the C-terminal TnI sequences in
the thin filament are thought to latch onto actin and constrain tropomyosin in
the blocked state at low-Ca2þ. Their dissociation from actin at high-Ca2þ
and association with the N-terminal lobe of Ca2þ-saturated TnC may relieve
the constraint (Galinksa-Rakoczy et al., 2008). These conclusions remain un-
certain, however, because troponin is only semi-rigid (so crystal packing forces
may have influenced the structure) and the troponin complex used for crystal-
lization contained truncated subunits. Here we have studied isolated, intact tro-
ponin molecules using negative stain electron microscopy and single-particle
image processing. Averaged projection views and 3D reconstructions of the
isolated molecules show many of the same features seen in the crystal struc-
tures. Comparison of reconstructions of low and high Ca2þ data suggests that
the TnC N-lobe of cardiac troponin may be further from the core domain in
the EM than in the crystal structure.
Funding: HSJ (KBSI-T29760); NIH: WL (HL36153), LST (HL38834,
HL63774), RC (AR34711, RR08426).
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The cardiac myofilament is a protein assembly that provides Ca-regulated force
development enabling the heart to undergo alternating periods of contraction
and relaxation. Troponin (Tn), a three-member protein assembly within the
myofilament, acts as a Ca-sensitive switch. Here, using single pair FRET in
freely diffusing assemblies of Tn, we show that Tn incompletely activates after
binding regulatory Ca. The reserved population of inactive Tn appears to func-
tion as a nanoscopic form of cardiac reserve that can be can be manipulated by
cell signaling mechanisms to fine-tune cardiac contractility. The results are dis-
cussed in terms of an energetic model of the cardiac myofilament.
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In vitro investigation of the effects of cardiomyopathy-causing mutations in
thin filament regulatory proteins has demonstrated that hypertrophic cardiomy-
opathy (HCM) and dilated cardiomyopathy (DCM) are caused by distinct pri-
mary alterations of cardiac contractility and myofilament calcium affinity. We
hypothesise that chronically altered calcium-buffering by mutant thin filaments
leads to altered calcium handling and, via calcium-dependent signalling path-ways, contributes to disease pathogenesis. We aim to study the in situ effect
on calcium flux of a HCM and a DCM causing mutation in human cardiac tro-
ponin T (cTnT) (R92Q, R131W respectively), by adenoviral mediated expres-
sion of mutant protein in adult guinea pig cardiomyocytes. The adenoviral vec-
tors co-express GFP and western blot analysis of FACS-sorted, GFP-expressing
cells showed that recombinant cTnT comprised 45-50% of the total cTnT in
these cardiomyocytes, 48 hours after infection. Analysis of unloaded sarcomere
shortening showed that at an excitation frequency of 2 Hertz, cardiomyocytes
infected with R131W cTnT elongated the time to 50% relaxation and reduced
the magnitude of contraction, whilst R92Q cTnT reduced the time to 50% re-
laxation and increased the contractile magnitude compared to wild type. Anal-
ysis of calcium transients of the same cells using fura-2 loading, indicates that
the R92Qmutation reduces calcium transient amplitude, whilst the R131Wmu-
tation increases the time to complete calcium reuptake, with no change to the
transient amplitude, despite the observed decrease in contraction. We are
currently assessing the caffeine transients of these cells to investigate alter-
ations to overall SR load and measuring alterations to components of cal-
cium-dependent signalling cascades which may link the acute effects of
cTnT mutations to macroscopic remodelling observed in the pathological dis-
ease states of HCM and DCM.
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Smooth muscle contraction is driven by cyclical, nucleotide-dependent changes
in myosin conformation that alter its affinity for actin, produce force, and gen-
erate movement. We used a high throughput screen to identify compounds that
inhibit the ATPase activity of smooth muscle myosin; optimization of the ini-
tial hit compounds has resulted in compounds with nanomolar affinity. A potent
representative of this chemical series, CK-2018571, inhibits the steady-state
ATPase activity of human smooth muscle myosin at low nanomolar concentra-
tions, approximately 10-fold lower than are required to inhibit non-muscle my-
osin, the most closely related myosin II. Selectivity between smooth and stri-
ated myosin IIs are >100-fold. Transient kinetic studies demonstrate that
CK-2018571 inhibits the myosin-catalyzed hydrolysis of the g-phosphate
group of ATP, with no effect on nucleotide binding or release from the enzyme.
Actin co-sedimentation assays indicate that CK-2018571 stabilizes a weak ac-
tin-binding conformation of myosin in the presence of ATP. Consistent with
this mechanism, CK-2018571 relaxes skinned rat tail artery muscle tissue at
low micromolar concentrations. Importantly, this relaxation occurs regardless
of whether the skinned muscle has been activated by calcium or by thiophos-
phorylation of the myosin regulatory light chain, supporting evidence that
CK-2018571 relaxes smooth muscle tissue by direct inhibition of activated
smooth muscle myosin. The ability of CK-2018571 to relax intact tracheal
smooth muscle and aortic ring preparations at micromolar concentrations sug-
gests this mechanism may prove useful in diseases of smooth muscle hyper-
contractility, such as hypertension and asthma.
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Both the Ca2þ signal and the alteration of the Ca2þ sensitivity of the contractile
apparatus regulate smooth muscle contraction. Myosin light chain kinase
(MLCK) phosphorylated the 20 kDa regulatory myosin light chain (MLC20)
resulting in contraction. Myosin light chain phosphatase (MLCP) dephosphor-
ylates MLC20 causing relaxation. Thus, the balance between the activities of
MLCK and MLCP determines the level of MLC20 phosphorylation.
MLCP consists of a 38 kDa catalytic subunit (PP1cd), a 110 kDa targeting sub-
unit (MYPT1), and a 21 kDa small subunit (M21). MYPT1 provides the sub-
strate specificity and the regulation of phosphatase activity. It was reported
that myosin phosphatase-Rho interacting protein (M-RIP) bound MYPT1 and
thus targeted MLCP to the actomyosin contractile filament based on yeast-
two hybrid and cell biological assays.
To determine if MYPT1 binds to M-RIP directly, we performed analytical ul-
tracentrifugation (AUC) study using purified peptides of MYPT1 and M-RIP.
354a Monday, February 22, 2010Circular dichroism and AUC analysis illustrated that the M-RIP peptide span-
ning residues 724-878 of M-RIP is a coiled coil and forms a dimer. The AUC
analysis demonstrated that the C-terminal coiled-coil region of MYPT1 span-
ning residues 924-991 did not bind the M-RIP peptide, whereas the C-termi-
nal random coiled-coil region of MYPT1 (synthetic LZ) spanning residues
991-1030 did bind, forming a heterotrimer. In addition, three individual
glutamic acid residues (amino acids 998-1000) of MYPT1 were critical for
binding. We replaced the glutamic acids either all three at a time or one at
a time with glutamine residues. In addition, we replaced all three glutamic
acids with aspartic acids. However none of these mutants bound to synthetic
LZ demonstrating that these three glutamic acid residues are essential for
binding.
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Themechanism of forcemaintenance in smoothmuscle has yet to be elucidated,
but recent evidence suggests that nonmuscle myosin IIB (NMIIB) contributes to
the mechanical properties of smooth muscle. This study was designed to deter-
mine the affects of NMIIB on the overall cross-bridge cycling rate. Aortic
smooth muscle strips from homozygous NMIIB KO (Bþ/) and WT littermates
were stimulated to contract (80 mMKCl) and the force response to a sinusoidal
change in length (~1% Lo) at frequencies between 0.25 and 125 Hz was re-
corded. The length perturbation and the corresponding force were expanded
into Fourier series to calculate the stiffness and phase frequency responses and
the data was illustrated in Bode diagrams. Steady state tension was significantly
less for the Bþ/ than for theWTmice. Frequency analysis revealed two distinct
regions in the Bode plots, and the individual regions were fit to find the asymp-
totes representing the low and high frequency regions. The intersection of the
two asymptotes occurred at 12.8650.243 Hz for WT and 17.3350.261 Hz
for Bþ/. Further, the slope of the relationship between tension/stiffness and fre-
quency was significantly higher for the WT than Bþ/mice. These data suggest
inWTmice that the force per attached cross-bridge is higher and duty cycle lon-
ger. These data demonstrate a decrease in NMIIB produces a fall in the force per
attached cross-bridge and an increase in the overall cross-bridge cycling rate.
These data could suggest that a decrease in the relative expression of NMIIB
would decrease steady state force more than stiffness to decrease both the force
per attached cross-bridge and internal load to shortening and result in an increase
in the overall cross-bridge cycling rate.
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A novel accelerated molecular dynamics method (the Orthogonal Space Ran-
dom Walk algorithm, OSRW) is applied to study the effect of the regulatory
light chain (RLC) phosphorylation on the structure of the light chain binding
domain of smooth muscle myosin. Smooth muscle myosin is activated by phos-
phorylation on the S19 (and T18 subsequently) at the N-terminus of the RLC
that causes a conformational change from the closed inhibited asymmetric
structure (Wendt et al. PNAS 2001) to the open structure by an unknown mech-
anism. The N-terminus also plays an important role in stabilizing the folded
10S conformation that is soluble at physiological ionic strength. However,
X-ray structures of the RLC do not show the 24-residue N-terminus, which
holds the phosphoration site. Thus, we are performing MD simulations on
the 21 residues of the N-terminus as well as the RLC with part of the heavy
chain. The phosphorylated N-terminus shows a bent a-helical conformation,
where the S19 interacts with the R16. The unphosphorylated N-terminus has
showed a straight a-helical conformation. Those simulations are carried out
in explicit water under near-physiological conditions. The OSRW has demon-
strated hundreds of times sampling capacity in compared with regular MD,
which will promote our understanding on the phophorylation activation mech-
anism. This work is supported by NIAMSD.1835-Pos
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Caldesmon is an actin- and myosin-binding protein that is rich in smooth
muscle. Caldesmon inhibits the actin activation of myosin catalyzed ATPase
activity and may have additional functions in smooth muscle. The activity of
caldesmon is controlled by phosphorylation and by binding to other factors
such as Caþþ-calmodulin. Caldesmon is a substrate for p21-activated kinase,
PAK, which is reported to phosphorylate chicken gizzard caldesmon at two
sites, Ser672 and Ser702. We investigated PAK phosphorylation of caldes-
mon using a 22kDa C-terminal caldesmon fragment. We also substituted
Ser672 and Ser702 with either alanine or aspartic acid residues to mimic
non-phosphorylated and constitutively phosphorylated states of caldesmon,
respectively. We found that the aspartic acid mutation of caldesmon weak-
ened calmodulin binding but had no effect on the inhibitory activity of cal-
desmon. Phosphorylation of the aspartic acid double mutant with recombi-
nant PAK resulted in additional phosphorylation at Thr627, Ser631, Ser635
and Ser642. Phosphorylation at these sites by PAK was slow, but produced
further weakening of calmodulin binding and reduced the inhibitory activity
of caldesmon in the absence of calmodulin. Phosphorylation at the additional
sites was without effect on Caþþ-Calmodulin binding if Ser672 and
Ser702 were not phosphorylated, but was sufficient to release inhibition of
actomyosin ATPase activity. This work raises the possibility that phosphor-
ylation in the region of residues 627-642 significantly alters the activity of
caldesmon.
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The regulation of arterial smooth muscle cell (SMC) contraction by adenine
and uridine nucleotides, plays a key role in controlling systemic blood pres-
sure. In SMCs, UTP activates P2Y receptors (subtypes 2/4/6), which couple
via Gaq/11-proteins to stimulate phospholipase C, increasing IP3/Ca
2þ concen-
trations and leading to SMC contraction. Continuous or repeated receptor
stimulation reduces responsiveness to further stimulation, a process termed de-
sensitization. Receptor desensitization is often regulated by G protein-coupled
receptor kinases (GRKs), which phosphorylate receptors, enhancing their inter-
action with b-arrestins and uncoupling them from G-proteins.
We investigated the regulation of receptors responding to UTP, which mediates
concentration-dependent contraction in rat mesenteric arteries. To characterize
adaptations that occur on repeated UTP additions, changes in IP3 and [Ca
2þ]i
were assessed using single-cell imaging. Receptor desensitization was assessed
by challenging mesenteric SMCs with an EC50 concentration of UTP (10 mM)
for 30 sec before (R1) and after (R2) the addition of a maximal UTP concen-
tration (Rmax, 100 mM, 30 sec) with 5 min washout periods. The change in
R2 relative to R1 was used to characterize P2Y receptor desensitization. By ex-
tending the washout period after Rmax a time-dependent recovery of IP3/Ca
2þ
responses were observed. To evaluate the involvement of individual GRKs in
this process, cells were transfected with catalytically-inactive, dominant-nega-
tive GRK mutants.
Using IP3 generation to indicate receptor recovery (R2/R1%), over-expression
of D110A,K220RGRK3 (3454%), K215RGRK5 (3857%), or K215RGRK6
(2958%) caused similar reductions in IP3 levels to those in empty-vector-
transfected cells (2355%). In contrast, expression of D110A,K220RGRK2
(5857%) markedly attenuated receptor desensitization (n=10-19 cells, >3 an-
imals). Furthermore, siRNA-mediated knockdown (>75%) of GRK2 protein
also attenuated agonist-induced receptor desensitization compared to control
(6858% versus 2956%, respectively, n¼8-12). In conclusion, this work im-
plicates GRK2 as the pre-eminent GRK isoenzyme regulating UTP signaling in
SMCs.
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